Research output per year
Research output per year
Personal profile
Research interests
During my training I pursued my interest in solid tumor oncology and completed several research projects in breast medical oncology, with a specific interest in clinical outcomes in geriatric patients. Although a large number of older adults are diagnosed with breast cancer, these patients are often unfortunately excluded from clinical trials and more research is needed to better understand clinical outcomes and toxicities of novel therapeutics in this population. During my training, I completed a project which examined progression free survival and toxicities of CDK inhibitors in a geriatric population.
Fingerprint
Dive into the research topics where Katherine Clifton is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling
Gerratana, L., Davis, A. A., Foffano, L., Reduzzi, C., Rossi, T., Medford, A., Clifton, K., Shah, A. N., Bucheit, L., Velimirovic, M., Bandini, S., Dai, C. S., Wehbe, F., Gradishar, W. J., Behdad, A., Ulivi, P., Ma, C. X., Puglisi, F., Bardia, A. & Cristofanilli, M., Jan 28 2025, In: Cancer Letters. 609, 217325.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer
Podany, E. L., Foffano, L., Gerratana, L., Medford, A. J., Clifton, K., Tapiavala, S., Velimirovic, M., Lipsyc-Sharf, M., Reduzzi, C., Bubie, A., Putur, A., Ademuyiwa, F. O., Puglisi, F., Gradishar, W. J., Ma, C. X., Bardia, A., Cristofanilli, M. & Davis, A. A., Feb 26 2025, In: JAMA Network Open. 8, 2, p. e2461899Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Ravani, L. V., Calomeni, P., Vilbert, M., Madeira, T., Wang, M., Deng, D., Testa, L., Colombo Bonadio, R., Clifton, K., Wander, S. A. & Lustberg, M., 2024, (Accepted/In press) In: JCO Oncology Practice. e00649.Research output: Contribution to journal › Article › peer-review
-
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Ademuyiwa, F. O., Northfelt, D. W., O’Connor, T., Levine, E., Luo, J., Tao, Y., Hoog, J., Laury, M. L., Summa, T., Hammerschmidt, T., Guo, Z., Frith, A., Weilbaecher, K., Opyrchal, M., Aft, R., Clifton, K., Suresh, R., Bagegni, N., Hagemann, I. S. & Iglesia, M. D. & 1 others, , Dec 2023, In: npj Breast Cancer. 9, 1, 1.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis
Gerratana, L., Davis, A. A., Velimirovic, M., Reduzzi, C., Clifton, K., Bucheit, L., Hensing, W. L., Shah, A. N., Pivetta, T., Dai, C. S., D’Amico, P., Wehbe, F., Medford, A., Wander, S. A., Gradishar, W. J., Behdad, A., Ma, C. X., Puglisi, F., Bardia, A. & Cristofanilli, M., 2023, In: JCO Precision Oncology. 7, e2200531.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations